Luminex Raises $74M in Public Offering | GenomeWeb
NEW YORK (GenomeWeb News) – Luminex has closed its public offering of 4,025,000 shares of common stock, including the over-allotment option of 525,000 shares, raising roughly $74.3 million in net proceeds.
 
The offering was priced at $19.91 per share, which was Luminex’s closing price on June 24. In late Monday afternoon trade, the firm’s shares were down .5 percent at $20.68.
 

Get the full story

This story is free
for registered users

Registering provides access to this and other free content.

Register now.

Already have an account?
Login Now.

In Nucleic Acids Research this week: nanopore sequencing workflow to detect antibiotic resistance in gut microbes, TSSPlant tool, and more.

Because gene-edited organisms can cross borders, Gizmodo wonders whether there should be an international body to govern their use.

HHS Secretary nominee Tom Price is to go in front of the Senate Committee on Health, Education, Labor and Pensions today, NPR's Morning Edition reports.

Prior to being closed, Theranos' Arizona lab failed an inspection by regulators, according to the Wall Street Journal.